World's Best Scientists 2026 revealed!
Matthias Geyer

Matthias Geyer

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
17081
World Ranking
5410
National Ranking
393

Overview

Matthias Geyer is affiliated with the University of Bonn in Germany, focusing primarily on biochemistry, genetics, and molecular biology. Their research portfolio encompasses 133 publications in these fields, with additional contributions in medicine totaling 69 publications.

Their work covers various subfields including molecular biology, immunology, oncology, physiology, and genetics. Specific topics frequently addressed by Matthias Geyer include inflammasome and immune disorders, interferon and immune responses, RNA research and splicing, RNA modifications and cancer, cancer-related molecular pathways, IL-33, ST2, and ILC pathways, as well as genomics and chromatin dynamics.

Among recent scientific papers authored or co-authored by Geyer are:

  • Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape, 2021, Science
  • Rational discovery of molecular glue degraders via scalable chemical profiling, 2020, Nature Chemical Biology
  • Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3, 2022, Nature
  • 1,6-Hexanediol, commonly used to dissolve liquid-liquid phase separated condensates, directly impairs kinase and phosphatase activities, 2021, Journal of Biological Chemistry
  • β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia, 2020, Cell Reports

Geyer collaborates frequently with several researchers, including Gregor Hagelueken, Ines H. Kaltheuner, Inga V. Hochheiser, Jonas Moecking, and Florian I. Schmidt. These collaborations reflect ongoing contributions to multiple aspects of molecular and cellular biology.

Publication venues where Matthias Geyer has contributed include bioRxiv (Cold Spring Harbor Laboratory) with 22 publications, Nature Communications with 7, Journal of Biological Chemistry with 4, Nature Chemical Biology with 3, and The Journal of Experimental Medicine with 3.

Best Publications

  • Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease

    Carmen Venegas;Sathish Kumar;Bernardo S. Franklin;Tobias Dierkes

  • The RNA Polymerase II Carboxy-Terminal Domain (CTD) Code

    Dirk Eick;Matthias Geyer

  • Structure–function relationships in HIV-1 Nef

    Matthias Geyer;Oliver T Fackler;B Matija Peterlin

  • Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape.

    Paul-Albert Koenig;Hrishikesh Das;Hejun Liu;Beate M. Kümmerer

  • Activation of Vav by Nef Induces Cytoskeletal Rearrangements and Downstream Effector Functions

    Oliver T Fackler;Wen Luo;Matthias Geyer;Arthur S Alberts

  • Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTP-binding proteins.

    Thomas Schweins;Matthias Geyer;Klaus Scheffzek;Arieh Warshel

  • Formins as effector proteins of Rho GTPases

    Sonja Kühn;Matthias Geyer

  • The Control of HIV Transcription: Keeping RNA Polymerase II on Track

    Melanie Ott;Matthias Geyer;Qiang Zhou

  • Fifteen formins for an actin filament: A molecular view on the regulation of human formins

    André Schönichen;Matthias Geyer

  • Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

    Tinghu Zhang;Nicholas Kwiatkowski;Nicholas Kwiatkowski;Calla M Olson;Sarah E Dixon-Clarke

  • NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

    Andrea Stutz;Carl-Christian Kolbe;Rainer Stahl;Gabor L. Horvath

  • Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP.

    Matthias Geyer;Thomas Schweins;Christian Herrmann;Thomas Prisner

  • Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation

    Friederike Itzen;Ann Katrin Greifenberg;Ann Katrin Greifenberg;Christian Andreas Bösken;Christian Andreas Bösken;Matthias Geyer;Matthias Geyer

  • CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer.

    Shawn F. Johnson;Cristina Cruz;Ann Katrin Greifenberg;Ann Katrin Greifenberg;Sofia Dust;Sofia Dust

  • Rational discovery of molecular glue degraders via scalable chemical profiling

    Cristina Mayor-Ruiz;Sophie Bauer;Matthias Brand;Zuzanna Kozicka;Zuzanna Kozicka

  • Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition

    Nadine Czudnochowski;Christian A. Bösken;Matthias Geyer

  • GEFs, GAPs, GDIs and effectors: taking a closer (3D) look at the regulation of Ras−related GTP−binding proteins

    Matthias Geyer;Alfred Wittinghofer

  • FMNL2 drives actin-based protrusion and migration downstream of Cdc42.

    Jennifer Block;Dennis Breitsprecher;Sonja Kühn;Moritz Winterhoff

  • Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription

    Matjaz Barboric;Jasper H. N. Yik;Nadine Czudnochowski;Zhiyuan Yang

  • CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation.

    Malgorzata Krajewska;Ruben Dries;Andrew V. Grassetti;Sofia Dust

Frequent Co-Authors

Hans Robert Kalbitzer
Hans Robert Kalbitzer University of Regensburg
Oliver T. Fackler
Oliver T. Fackler University Hospital Heidelberg
B. Matija Peterlin
B. Matija Peterlin University of California, San Francisco
Eicke Latz
Eicke Latz German Rheumatism Research Centre
Serge Benichou
Serge Benichou Grenoble Alpes University
Alfred Wittinghofer
Alfred Wittinghofer Max Planck Society
Frank Kirchhoff
Frank Kirchhoff University of Ulm
Christian Herrmann
Christian Herrmann Ruhr University Bochum
Nathanael S. Gray
Nathanael S. Gray Stanford University
Tinghu Zhang
Tinghu Zhang Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Matthias Geyer

Trending Scientists